Published by Coherent Market Insights
Posted on September 20, 2021
Coherent Market Insights released a new market study on 2021-2027 Radiofrequency Ablation Devices Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Radiofrequency Ablation Devices Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4252
Radiofrequency Ablation is a painless procedure that is done using a narrow needle and a low-level electrical current. The Radiofrequency Ablation procedure is performed by placing a very thin stainless steel needle into each individual follicle. The needle sends out an electrical charge that destroys the follicle so that it will not grow back and cause the surrounding tissue to be inflamed and damaged. It is also less painful and causes less tissue damage. In addition, Radio Frequency Ablation can be performed on almost any area of the skin. This means that it can be used to treat not only acne but also stretch marks, fine lines, and wrinkles, as well as hyperpigmentation and facial spots.
The growing use of ablation devices for pain management is driving the growth of the global radiofrequency ablation devices market. So, the increasing prevalence of arthritis around the globe is uplifting the growth of the market. According to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have been diagnosed with arthritis, which accounted for around 1 in 4 people in the U.S. Moreover, the growing geriatric population is also projected to augment the growth of the radiofrequency ablation devices market. According to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Furthermore, the growing demand for minimally invasive procedures is further projected to foster the growth of the market over the forecast period.
North America is expected to exhibit significant growth over the forecast period and this is attributed to the continuous innovation by ley players in the field of radiofrequency ablation devices. For instance, in November 2020, Abbott announced the launch of the IonicRF
Generator – a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
Key Developments:
In May 2019, Boston Scientific Corporation entered into a definitive agreement to acquire Vertiflex, Inc., a developer of minimally-invasive devices for pain management.
In February 2019, Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues.
Radiofrequency Ablation Devices Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Accuray, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., St. Jude Medical, Inc., and Stryker Corporation.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4252
Reasons to Purchase this Report
• Current and future of global Radiofrequency Ablation Devices Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Radiofrequency Ablation Devices Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4252
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post The radiofrequency ablation devices market for pain management is estimated to account for US$ 1,465.1 Mn in 2020 and is expected to reach US$ 5,075.1 Mn in terms of value by the end of 2027. appeared first on Gatorledger.
Coherent Market Insights released a new market study on 2021-2027 Radiofrequency Ablation Devices Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Radiofrequency Ablation Devices Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4252
Radiofrequency Ablation is a painless procedure that is done using a narrow needle and a low-level electrical current. The Radiofrequency Ablation procedure is performed by placing a very thin stainless steel needle into each individual follicle. The needle sends out an electrical charge that destroys the follicle so that it will not grow back and cause the surrounding tissue to be inflamed and damaged. It is also less painful and causes less tissue damage. In addition, Radio Frequency Ablation can be performed on almost any area of the skin. This means that it can be used to treat not only acne but also stretch marks, fine lines, and wrinkles, as well as hyperpigmentation and facial spots.
The growing use of ablation devices for pain management is driving the growth of the global radiofrequency ablation devices market. So, the increasing prevalence of arthritis around the globe is uplifting the growth of the market. According to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have been diagnosed with arthritis, which accounted for around 1 in 4 people in the U.S. Moreover, the growing geriatric population is also projected to augment the growth of the radiofrequency ablation devices market. According to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Furthermore, the growing demand for minimally invasive procedures is further projected to foster the growth of the market over the forecast period.
North America is expected to exhibit significant growth over the forecast period and this is attributed to the continuous innovation by ley players in the field of radiofrequency ablation devices. For instance, in November 2020, Abbott announced the launch of the IonicRF Generator – a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
Key Developments:
In May 2019, Boston Scientific Corporation entered into a definitive agreement to acquire Vertiflex, Inc., a developer of minimally-invasive devices for pain management.
In February 2019, Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues.
Radiofrequency Ablation Devices Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Accuray, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., St. Jude Medical, Inc., and Stryker Corporation.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4252
Reasons to Purchase this Report
• Current and future of global Radiofrequency Ablation Devices Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Radiofrequency Ablation Devices Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4252
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post The radiofrequency ablation devices market for pain management is estimated to account for US$ 1,465.1 Mn in 2020 and is expected to reach US$ 5,075.1 Mn in terms of value by the end of 2027. appeared first on Gatorledger.
Explore more articles in the Research Reports category
